Published on
At the invitation of the White House, CHOP sent two guests to President Obama’s announcement of the Precision Medicine Initiative: Dr. Altschuler and Emily Whitehead.
Published on
As more children present with skin lesions that may have potential for malignancy, CHOP has formed a team to provide a consistent, multidisciplinary approach to evaluation and care.
Published on
Arriving at a diagnosis and deciding on a treatment plan for HLH is a complex process. The newly formed HLH treatment team at CHOP helps physicians order the right tests, interpret the results, and plan treatment.
Published on
Ninety percent of patients with ALL who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019.
Published on
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study.
Published on
From now until Dec. 9, Ellen DeGeneres is auctioning a celebrity-autographed Cincinnati Bengals football jersey, with all proceeds benefiting Cancer Research at The Children's Hospital of Philadelphia.
Published on
CHOP announces the selection of Stephen P. Hunger, MD, a nationally prominent specialist in children’s cancer, as its new chief of the Division of Oncology and the director of the Center for Childhood Cancer Research.
Published on
CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.
Published on
During the month of November, take some time to recognize parents and caregivers for the love, support and care they provide their children and loved ones every day.
Published on
The Children’s Hospital of Philadelphia co-developed and treated 25 children with aggressive leukemia using this new therapy.